Enveda Biosciences Funding: $230M Raised, Series D (2025)
Enveda Biosciences is a Biotech company based in Boulder, Colorado. It has raised $230M in total funding. Latest round: Series D.
Enveda Biosciences funding overview
Enveda Biosciences is a Biotech company based in Boulder, Colorado. Enveda Biosciences has raised $230M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in July 2025. The round record for Enveda Biosciences runs through 2025; nothing later has been disclosed. Investors on record include Premji Invest, Kinnevik, Dimension, Lux Capital, Microsoft, The Nature Conservancy and 5 others. 11 distinct backers are named across the disclosed rounds.
Enveda Biosciences has raised $230M in total disclosed funding across the rounds on record.
Who has invested in Enveda Biosciences?
Premji Invest, Kinnevik, Dimension, Lux Capital, Microsoft, The Nature Conservancy are named among the investors backing Enveda Biosciences.
What was the latest Enveda Biosciences funding round?
The most recent disclosed round is a Series D, announced in July 2025.
Where is Enveda Biosciences based?
Enveda Biosciences is based in Boulder, Colorado.
What sector does Enveda Biosciences operate in?
Enveda Biosciences is tracked under Biotech from Boulder, Colorado, with $230M in disclosed funding.
When did Enveda Biosciences last raise?
The last disclosed Enveda Biosciences round closed in July 2025 at Series D.
Round data for Enveda Biosciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Boulder and backer lists below.
